Monitor for additional funding announcements and stockholder approval for warrant issuance, as the company remains at risk of delisting from Nasdaq and may need further capital to continue operations beyond August 2026.
Price Chart
Executive Summary
Outlook Therapeutics is raising $4.65 million through a registered offering of 16.1 million shares at $0.31 per share, accompanied by warrants to purchase an equal number of shares at the same price. The proceeds will extend the company's cash runway into August 2026, but substantial doubt remains about its ability to continue as a going concern. The company also amended existing warrants to lower their exercise price from $2.26 to $0.31, reflecting financial distress.
Key Facts
- Offering 16,129,033 shares at $0.31 per share, raising gross proceeds of $5 million
- Concurrent private placement of warrants to purchase 16,129,033 shares at $0.31 per share
- Net proceeds estimated at $4.65 million after placement agent fees
- Company has substantial doubt about its ability to continue as a going concern
- Cash runway extended to August 2026, but additional funding will be required
- Amended existing warrants from $2.26 to $0.31 exercise price, indicating financial distress
- Common stock trading at $0.32, below $1.00 Nasdaq listing requirement
Financial Impact
Raises $4.65 million in net proceeds, but results in significant dilution to existing shareholders
Risk Factors
- Substantial doubt about the company's ability to continue as a going concern
- Risk of delisting from Nasdaq due to share price below $1.00 minimum
- Significant dilution from the offering and warrant amendments
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 424B5 Filing (Primary) | 0001104659-26-047242 |
| Document: 0001104659-26-047242-index-headers.html | 0001104659-26-047242 |
| Document: 0001104659-26-047242-index.html | 0001104659-26-047242 |
| Document: 0001104659-26-047242.txt | 0001104659-26-047242 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 14, 2026 7w ago | 8-K | $0.7564 $0.6379 | ▲ +15.67% | ▲ +13.67% | $0.5778 (+23.61%) |
Aug 14, 2026 7w ago | 424B5 | $0.7564 $0.6379 | ▲ +15.67% | ▲ +13.67% | $0.5778 (+23.61%) |
Aug 14, 2026 7w ago | 8-K | $0.7564 $0.6379 | ▲ +15.67% | ▲ +13.67% | $0.5778 (+23.61%) |
Aug 14, 2026 7w ago | Press Release | $0.7564 $0.6379 | ▼ −15.67% | ▼ −13.67% | $0.5778 (−23.61%) |
Aug 13, 2026 7w ago | Press Release | $0.8888 $0.6600 | ▲ +25.74% | ▲ +24.00% | $0.5778 (+34.99%) |
Aug 12, 2026 7w ago | 8-K | $0.8888 $0.6600 | ▲ +25.74% | ▲ +24.00% | $0.5778 (+34.99%) |
Jul 24, 2026 9w ago | 8-K | $1.07 $0.6090 | ▼ −42.82% | ▼ −46.12% | $0.5778 (−45.75%) |
Jul 24, 2026 10w ago | Press Release | $1.41 $0.6472 | ▼ −53.94% | ▼ −57.56% | $0.5778 (−58.88%) |
Jul 23, 2026 10w ago | 8-K | $1.41 $0.6472 | ▼ −53.94% | ▼ −57.56% | $0.5778 (−58.88%) |
Jul 22, 2026 10w ago | EFFECT | $1.34 $0.6901 | ▼ −48.50% | ▼ −51.40% | $0.5778 (−56.88%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access